DOBUTAMINE SUN 5 mg/ml, solution for infusion in a pre-filled syringe syringe, 50 ml
Active ingredients: DL-dobutamine hydrochloride, DOBUTAMINE BASE
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusionsyringe, 50 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DOBUTAMINE SUN 5 mg/mL, solution pour perfusion en seringue pré-remplie
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 seringue(s) préremplie(s) copolymère de cyclooléfines suremballée(s)/surpochée(s) de 50 ml
- Marketing authorisation holder
- SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 4 Apr 2025
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66475574CIP75508533CIP133400955085331Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE DOBUTAMINEsolution | — | SA |
| DOBUTAMINE BASEsolution | 5 mg · 1 mL de solution pour perfusion | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.